RUNX1–Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors-Reference-Cited by-同舟云学术

RUNX1–Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors

Published:2022-12-12 Issue:12 Volume:45 Page:886-895
ISSN:0219-1032
Container-title:Molecules and Cells
language:en
Short-container-title:Mol.Cells

Author:

Mikami Masamitsu¹^ORCID,Masuda Tatsuya²,Kanatani Takuya²,Noura Mina²,Umeda Katsutsugu¹^ORCID,Hiramatsu Hidefumi¹^ORCID,Kubota Hirohito¹^ORCID,Daifu Tomoo¹^ORCID,Iwai Atsushi¹,Hattori Etsuko Yamamoto²^ORCID,Furuichi Kana²,Takasaki Saho²,Tanaka Sunao²,Matsui Yasuzumi²,Matsuo Hidemasa²^ORCID,Hirata Masahiro³,Kataoka Tatsuki R.³^ORCID,Nakahata Tatsutoshi⁴^ORCID,Kuwahara Yasumichi⁵^ORCID,Iehara Tomoko⁶,Hosoi Hajime⁶,Imai Yoichi⁷^ORCID,Takita Junko¹^ORCID,Sugiyama Hiroshi⁸^ORCID,Adachi Souichi²^ORCID,Kamikubo Yasuhiko²^ORCID

Affiliation:

1. Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan

2. Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan

3. Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto 606-8507, Japan

4. Drug Discovery Technology Development Office, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan

5. Department of Biochemistry and Molecular Biology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan

6. Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan

7. Department of Hematology/Oncology, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan

8. Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto 606-8303, Japan

Funder

University of Tokyo

Publisher

Korean Society for Molecular and Cellular Biology

Subject

Cell Biology,Molecular Biology,General Medicine

Link

http://pdf.medrang.co.kr/KSMCB/2022/045/KSMCB045-12-04.pdf

Reference35 articles.

1. Adida C., Crotty P.L., McGrath J., Berrebi D., Diebold J., and Altieri D.C. (1998). Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am. J. Pathol. 152, 43-49.

2. The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes

3. Synthesis and Biological Properties of Sequence-Specific DNA-Alkylating Pyrrole−Imidazole Polyamides

4. Addiction of t(8;21) and inv(16) Acute Myeloid Leukemia to Native RUNX1

5. Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study—EpSSG NRSTS 2005

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting cis-regulatory elements of FOXO family is a novel therapeutic strategy for induction of leukemia cell differentiation;Cell Death & Disease;2023-09-29